Opioids and Responsible Prescribing

CME/CE credit:  Up to 8 AMA PRA Category 1 CreditsTM
Length of Time for Completion: 8+ hours
Number of questions to complete: All available questions

Planning Committee, Writers, and Reviewers

Amy Rontal, MD: Planner, Reviewer 
Director of Medical Content, Blueprint Test Prep/Rosh Review 
Assistant Professor of Emergency Medicine 
Beaumont Health Systems/Oakland University

Yi-Kuan Chen, MD: Planner, Writer, Reviewer
Family Medicine Physician
Content Champion – Family Medicine, Blueprint Test Prep/Rosh Review

Target Audience: Physicians, physician assistants, and nurse practitioners
Learning Objectives:
Upon completion of this educational activity, participants will be able to:

  • Comprehensively review content covering pharmacology, recognition and treatment of opioid toxicity and withdrawal, opioid and substance use disorders, and responsible prescribing practices
  • Effectively translate the acquired academic knowledge into improved diagnostics and subsequently implement a better treatment plan for their patients.

Accreditation:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Wayne State University School of Medicine and Rosh Review. The Wayne State University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Designation of Credit:
The Wayne State University School of Medicine designates this enduring material for a maximum of 8 AMA PRA Category 1 CreditsTM. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Information
Disclosures: Wayne State University School of Medicine requires that everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with ineligible companies. “Ineligible companies” are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients

No commercial relationships with ineligible companies:

Amy Rontal, MD
Yi-Kuan Chen, MD

Investigational and/or Off-Label Use of Commercial Products and Devices:
There is no mention of investigational and/or off-label use of commercial products.

Acknowledgment of Commercial Support: There is no commercial support received for this educational activity.

Technical Requirements: Internet connection

For CME-related questions about this activity, contact Taylor Lauzon at cme@roshreview.com